These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aminoglycoside prescribing and surveillance in cystic fibrosis. Tan KH; Mulheran M; Knox AJ; Smyth AR Am J Respir Crit Care Med; 2003 Mar; 167(6):819-23. PubMed ID: 12623858 [No Abstract] [Full Text] [Related]
5. [Management of aspirin discontinuation in stable coronary heart disease prior to elective surgery]. Collet JP Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):652-5. PubMed ID: 12555473 [No Abstract] [Full Text] [Related]
7. Putting a stop to thrombi. Palatnik A Nursing; 2007; 37 Suppl Cardiac():2-6. PubMed ID: 18075484 [TBL] [Abstract][Full Text] [Related]
8. GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents? Tricoci P; Newby LK Cardiol Rev; 2008; 16(2):89-94. PubMed ID: 18281911 [TBL] [Abstract][Full Text] [Related]
9. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity. Price MJ Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982 [No Abstract] [Full Text] [Related]
10. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. May AE; Geisler T; Gawaz M Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396 [TBL] [Abstract][Full Text] [Related]